Help us make childhood cancer universally survivable.

By giving monthly, you directly support our continued research into discovering effective and less toxic treatments for childhood cancer.

Support Our Lab

$
Select Payment Method
Personal Info

Credit Card Info
This is a secure SSL encrypted payment.
Billing Details

I want to dedicate this donation to someone

In honor of... Details

Donation Total: $25.00 One Time

Our team is on a mission to make childhood cancer universally survivable!

The FDA approves on average 12 drugs every year to treat adult cancer, but has only approved 10 drugs to treat childhood cancer since 1978 (10 in 44 years for kids).

Since our inception in 2015, cc-TDI has pushed two drugs into three clinical trials to treat childhood cancer.

giving back childhood for

#GIVINGBACKCHILDHOOD

Latest News

Your Support Matters

My name is Amy, and I am the proud mom of two amazing boys, Avery and Evan. Our son Avery has battled embryonal rhabdomyosarcoma for three and a half years, enduring multiple rounds of chemotherapy and radiation in an attempt to fight this disease.   When your child is first diagnosed with cancer you are bewildered and terrified. You are catapulted into a world that you didn’t even know existed. Then, once you wrap your head around the battle you are going to fight, you begin searching. Searching for reasons, answers, specialized treatment options and here’s

Read More »

Current Research Projects

A dedicated research team

Our research team is exploring and testing state-of-the-art treatment options for the most urgent issues facing children with cancer. 

Working in our own freestanding research institution allows us to act swiftly and nimbly to achieve results—bringing cost control, speed, purpose, and focus to translate effective treatments into the clinic. To get there, we perform basic science and translational research in our industrial modern lab site (a paint factory remodeled by Nike as an off-site creative space), adjacent to the Silicon Forest in Oregon.